Epic Sciences Stock
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Sign up today and learn more about Epic Sciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Epic Sciences Stock
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
Funding History
| June 2009 | $2.5M |
|---|---|
| November 2012 | $13.0M |
| July 2014 | $30.0M |
| June 2015 | $15.0M |
| April 2017 | $40.0M |
| September 2018 | $52.0M |
Management
Chief Business Officer and General Counsel
Ian Miller
Chief of Medical Innovation; Head of Translational Research Partnerships
Ryan Dittamore
CSO & Head of Laboratory Operations
Pascal Bamford
Founder
David Nelson
CEO & President
Murali K. Prahalad
Press
patents - Apr, 14 2024
Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) …patents - Apr, 14 2024
Circulating tumor cell diagnostics for detection of neuroendocrine prostate …patents - Apr, 14 2024
Enhanced characterization of breast cancerpatents - Apr, 14 2024
Single cell genomic profiling of circulating tumor cells (CTCs) in metastatic …patents - Apr, 14 2024
ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS …EquityZen Recognized As:
